Markets:

Overview

News

Currencies

International

Treasuries

iShares Core S&P Small-Cap ETF (NY:IJR)

124.95 +0.03 (+0.02%)

Streaming Delayed Price Updated: 11:09 AM EDT, Apr 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Core S&P Small-Cap ETF

< Previous 1 2 3 4 5 6 7 8 9 Next >

Papa John's Stock Climbs After Q1 Revenue Beat Amid Challenging Times For Restaurants: Retail Mood Neutral ↗

May 12, 2025

Shares jumped 16% on Thursday following the results, leading to a third consecutive week of gains for the stock.

Via Stocktwits

ANI Pharma Reports Upbeat Q1 Earnings, Revises Full-Year Outlook: Retail’s Pleased ↗

May 09, 2025

The CEO dismissed the impact of Trump tariffs, noting that the company produces a major portion of its goods in the U.S.

Via Stocktwits

Topics Government World Trade

TG Therapeutics Stock Tumbles After Q1 Earnings Fall Short Of Wall Street Estimates: But Retail’s Optimistic ↗

May 05, 2025

The company, however, raised its full-year 2025 global net revenue target to approximately $575 million, up from its previous guidance of $540 million.

Via Stocktwits

Etsy Beats Q1 Revenue Estimates, Unveils Tariff Mitigation Plan: Retail Turns Very Optimistic ↗

April 30, 2025

Shares, however, fell amid a broad market selloff after new data on Wednesday showed contraction in the U.S. economy.

Via Stocktwits

Topics Economy World Trade

Sabre Stock Rockets After Divesting Hospitality Solutions Business To TPG In $1.1B Deal ↗

April 28, 2025

Sabre CEO Kurt Ekert stated that the divestiture will enable the company to focus on its core airline IT and travel marketplace platforms.

Via Stocktwits

Topics Artificial Intelligence

Channel Therapeutics Stock Soars On Announcement Of Subsidiary’s Merger With Ligand Pharma Units: Retail’s Elated ↗

April 17, 2025

Under the agreement, Ligand’s wholly owned subsidiaries, Pelthos Therapeutics Inc. and LNHC, Inc. will combine with CHRO Merger Sub Inc., a wholly-owned subsidiary of Channel.

Via Stocktwits

Bath & Body Works Stock Upgraded By Piper Sandler On Strong Brand Interest, Attractive Share Price: Retail Investors Very Interested ↗

April 13, 2025

The brand was a popular choice for fragrances among teenagers in the U.S., according to a Piper Sandler survey.

Via Stocktwits

Victoria's Secret Poaches Talent From Rivals, Beefs Up Top Deck To Revive Growth: Retail Investors Not Sold Yet ↗

April 09, 2025

The lingerie brand saw a 1% fall in net sales last year, and its shares are down over 60% from the December peak.

Via Stocktwits

Pacira Biosciences Stock Rises On Patent Litigation Settlement: Retail Sentiment Soars ↗

April 08, 2025

RBC Capital opined that Pacira's settlement of litigation for generic Exparel, which provides some closure to over a year's worth of overhang and uncertainty for shares, is a win for the company and...

Via Stocktwits

Topics Intellectual Property

30-Year-Old With $65K In Stocks Sparks Debate – 'Focusing Mostly On ETFs' But Now Betting On Bonds, Small Caps, And International Plays ↗

March 31, 2025

Many investors start their journey toward financial security with stocks, and a successful investing strategy involves considering the risks, adapting, and thinking about the long-term rewards.

Via Benzinga

Angi Set To Join S&P SmallCap 600 Index Next Week, Stock Rallies: Retail’s Upbeat ↗

March 27, 2025

The S&P SmallCap 600 Index includes 600 companies, representing about 3% of the U.S. market.

Via Stocktwits

Topics Stocks

Signet Jewelers Stock Shines Bright After Q4 Beat: Retail Confidence Sparkles ↗

March 20, 2025

For 2026, the company's guidance reflected sales that assume a measured consumer environment.

Via Stocktwits

Retail Traders Turn Bullish On Etsy Following Analyst Move Amid Macro Challenges ↗

March 19, 2025

JPMorgan analyst Bryan Smilek assigned a ‘Neutral’ rating with a $50 price target.

Via Stocktwits

Holiday Sales, Consumer Spending Trends Weigh On Signet Jewelers’ Stock Ahead Of Q4 Earnings, But Retail’s Optimistic ↗

March 19, 2025

Last week, Telsey Advisory lowered the price target to $55 from $65 with a Market Perform rating following the company’s disappointing holiday sales and Q4 guidance

Via Stocktwits

American Eagle's $200M Buyback Plan Lifts Retail Sentiment A Notch Even As Soft 2025 Guidance Weighs ↗

March 17, 2025

The company said it intends to complete the share purchase in connection with its existing authorization of 68.5 million shares.

Via Stocktwits

Risk-On Sentiment Falters For Global Asset Allocation Strategies ↗

March 17, 2025

The appetite for risk has taken a hit in recent weeks, although the worst of the selling has, so far, been contained to US stocks, on a year-to-date basis.

Via Talk Markets

Topics ETFs

Kohl’s Stock Dives On Disappointing Outlook, But Retail’s Optimistic Post Q4 Results ↗

March 12, 2025

Kohl’s posted better-than-expected earnings, with earnings per share of $0.95, surpassing estimates of $0.72.

Via Stocktwits

Kohl’s Corp Stock Rises Ahead of Q4 Earnings: Retail’s Upbeat About Further Uptick ↗

March 11, 2025

Wall Street analysts expect the company to post Q4 earnings per share of $3.52 on revenue of $3.78 billion.

Via Stocktwits

Victoria's Secret Stock Slips As Trump Tariff Jitters Outweigh Q4 Earnings Beat: Retail Cheers New CEO's Turnaround Efforts ↗

March 06, 2025

The company cited an "uncertain" macro environment, a shift in consumer confidence, and headwinds from unseasonal weather in the U.S.

Via Stocktwits

Topics Government

Adma Biologics' Retail Traders Eye Higher Open After Blowout Q4, Strong Full-Year Outlook ↗

March 03, 2025

CEO Adam Grossman highlighted a 65% year-over-year jump in total revenue and a staggering 309% increase in adjusted EBITDA for 2024.

Via Stocktwits

Retail Bets TG Therapeutics Stock Can Sustain Post-Earnings Gains Throughout The Week ↗

March 03, 2025

Annual revenue from its MS drug, Briumvi, more than tripled, with U.S. net product revenue reaching $103.6 million in the fourth quarter and $310 million for the full year.

Via Stocktwits

Bath & Body Works Stock Rises On Analyst Upgrade Citing Innovation, Improving Home Fragrance Market: Retail Stays Bullish ↗

March 03, 2025

Citi upgraded Bath & Body Works from ‘Neutral’ to ‘Buy’ following the company’s post-earnings share sell-off

Via Stocktwits

Cars.com Stock Snags Another Price Target Cut As Sell-Side Wary About Execution: Retail Stays Confident ↗

March 02, 2025

cars-com-stock-snags-another-price-target-cut

Via Stocktwits

DoubleVerify Stock Sinks On Lackluster Q4 Results, Weak Quarterly Guidance: Retail Sentiment Plummets ↗

February 28, 2025

The revenue miss was due to a slowdown in spending from existing customers that began in October and one of the company’s largest customers pulling back its business significantly.

Via Stocktwits

Papa John’s Serves Up Q4 Earnings Beat, But Retail Appetite Is Half-Baked ↗

February 28, 2025

Sentiment on Stocktwits remained ‘neutral’ compared to a week ago

Via Stocktwits

Topics Earnings

Bath & Body Works Stock Dives On Disappointing Earnings Guidance, China Tariff Warning — But Retail Stays Upbeat ↗

February 28, 2025

Its first quarter 2025 earnings per diluted share is expected to be between $0.36 and $0.43, compared to the consensus estimate of $0.44.

Via Stocktwits

Bloomin’ Brands Stock Dives To One-Year Low After Q4 Revenue Fall: Retail Sentiment Turns Gloomy ↗

February 27, 2025

Sentiment on Stocktwits turned ‘bearish’ compared to ‘bullish’ a week ago

Via Stocktwits

Topgolf Callaway Stock Rises After-Market On Q4 Earnings Beat: Retail Sentiment Brightens ↗

February 25, 2025

Segment-wise, revenue at ‘Topgolf’remained flat at $439.0 million

Via Stocktwits

Hims & Hers Stock Sinks After-Hours As Weight-Loss Roadmap Gets Clouded — Retail Pounces On The Dip ↗

February 24, 2025

On the earnings call, CEO Andrew Dudum acknowledged that the transition would be "inevitable" for patients currently on compounded semaglutide.

Via Stocktwits

Topics Earnings

Hims & Hers Retail Traders Eye Robust Post-Earnings Rebound Following Stock’s Worst Drop On Semaglutide Update ↗

February 24, 2025

CEO Andrew Dudum acknowledged retail shareholders in a post on X, highlighting their deep research on the company and announcing plans to engage them directly on future earnings calls.

Via Stocktwits

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.